John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
FuelCell Energy
FCEL
$1.54B
| $1.57M | ﹤0.01% |
43,887
-31,264
| -42% | -$1.15M |
|
1627
Capitol Federal Financial
CFFN
$1.05B
| $1.57M | ﹤0.01% |
262,823
+26,803
| +11% | +$159K |
|
1628
Zillow
ZG
$8.34B
| $1.57M | ﹤0.01% |
32,709
-4,598
| -12% | -$243K |
|
1629
Prudential
PUK
$35.3B
| $1.56M | ﹤0.01% |
+81,173
| New | +$1.68M |
|
1630
Addus HomeCare
ADUS
$2.26B
| $1.56M | ﹤0.01% |
15,126
-251
| -2% | -$23.5K |
|
|
BOWN
1631
DELISTED
Bowen Acquisition Corp
BOWN
| $1.56M | ﹤0.01% |
150,000
| – | – |
|
1632
InterContinental Hotels
IHG
$24.2B
| $1.56M | ﹤0.01% |
14,743
-21,875
| -60% | -$2.19M |
|
1633
Expedia Group
EXPE
$40.6B
| $1.56M | ﹤0.01% |
11,300
-592,099
| -98% | -$84.2M |
|
1634
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.56M | ﹤0.01% |
3,700
| – | – |
|
1635
Byline Bancorp
BY
$1.72B
| $1.55M | ﹤0.01% |
71,465
+11,171
| +19% | +$241K |
|
1636
Phillips 66
PSX
$94.5B
| $1.55M | ﹤0.01% |
9,500
-5,000
| -34% | -$721K |
|
|
OLPX
1637
DELISTED
Olaplex Holdings
OLPX
| $1.55M | ﹤0.01% |
808,059
-409,807
| -34% | -$854K |
|
1638
Radware
RDWR
$1.17B
| $1.55M | ﹤0.01% |
82,722
-22,938
| -22% | -$416K |
|
1639
RBC Bearings
RBC
$15.7B
| $1.55M | ﹤0.01% |
5,726
-23,414
| -80% | -$6.32M |
|
1640
CALL
BioMarin Pharmaceuticals
BMRN
$12.8B
| $1.55M | ﹤0.01% |
17,700
-100
| -0.6% | -$8.95K |
|
|
AITR
1641
DELISTED
AI Transportation Acquisition Corp
AITR
| $1.54M | ﹤0.01% |
+150,000
| New | +$1.54M |
|
1642
Tyler Technologies
TYL
$14.3B
| $1.54M | ﹤0.01% |
3,619
-15,807
| -81% | -$6.75M |
|
|
CVSA
1643
Covista Inc
CVSA
$4.64B
| $1.54M | ﹤0.01% |
29,864
+12,794
| +75% | +$668K |
|
|
AFJK
1644
Aimei Health Technology Co
AFJK
$38.9M
| $1.53M | ﹤0.01% |
+150,000
| New | +$1.53M |
|
|
USAP
1645
DELISTED
Universal Stainless & Alloy
USAP
| $1.53M | ﹤0.01% |
+68,349
| New | +$1.38M |
|
1646
Quetta Acquisition Corp
QETA
$44M
| $1.53M | ﹤0.01% |
150,000
| – | – |
|
|
GLAC
1647
DELISTED
Global Lights Acquisition Corp Ordinary Shares
GLAC
| $1.53M | ﹤0.01% |
150,000
| – | – |
|
1648
Fox Class A
FOXA
$29.6B
| $1.53M | ﹤0.01% |
48,800
-426,548
| -90% | -$13M |
|
|
DYCQU
1649
DELISTED
DT Cloud Acquisition Corp Unit
DYCQU
| $1.52M | ﹤0.01% |
+150,000
| New | +$1.52M |
|
1650
A10 Networks
ATEN
$1.82B
| $1.52M | ﹤0.01% |
110,755
-227,157
| -67% | -$3.05M |
|
Similar funds
John Overdeck's Q1 2024 Portfolio in Review
As of Q1 2024, John Overdeck held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
John Overdeck withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, John Overdeck opened a new position in Pfizer worth $234M.
- John Overdeck's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- John Overdeck added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- John Overdeck's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- John Overdeck fully exited Rivian in Q1 2024, selling an estimated $158M.
- John Overdeck's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- John Overdeck opened 408 new positions and closed 532 in Q1 2024.
- John Overdeck's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.